Intelligent Bio Solutions (NASDAQ:INBS) Trading Up 7% – Still a Buy?

Intelligent Bio Solutions Inc. (NASDAQ:INBS)’s share price traded up 7% on Wednesday . The stock traded as high as $1.29 and last traded at $1.23. 125,547 shares changed hands during trading, a decline of 77% from the average session volume of 546,753 shares. The stock had previously closed at $1.15.

Intelligent Bio Solutions Stock Performance

The stock has a 50-day moving average price of $1.94 and a 200-day moving average price of $1.66.

Intelligent Bio Solutions (NASDAQ:INBS) last released its earnings results on Thursday, February 13th. The company reported ($0.50) EPS for the quarter. The business had revenue of $610 billion for the quarter. Intelligent Bio Solutions had a negative net margin of 323.79% and a negative return on equity of 146.03%. As a group, research analysts predict that Intelligent Bio Solutions Inc. will post -1.25 EPS for the current year.

About Intelligent Bio Solutions

Intelligent Bio Solutions Inc, a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.